Kai-Cheng Chang

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 2

Top Topics

Top Venues

British journal of clinical pharmacology

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Po-Ting Lin, Min-Hua Hung, Shih-Chieh Shao, Hui-Yu Chen, Yuk-Ying Chan, Kai-Cheng Chang, Shi-Ming Lin, Huang-Tz Ou
Factors predictive of clinical outcome in advanced hepatocellular carcinoma patients receiving ramucirumab treatment: A real-world experience. Cancer medicine (2023)
Wen-Hsuan Hou, Kai-Cheng Chang, Chung-Yi Li, Huang-Tz Ou
Dipeptidyl peptidase-4 inhibitor use is associated with decreased risk of fracture in patients with type 2 diabetes: a population-based cohort study. British journal of clinical pharmacology 84 (9) (2018)